Long-acting beta-agonist (LABA) therapy improves symptoms in patients whose asthma is poorly controlled by an inhaled glucocorticoid alone. Alternative treatments for adults with uncontrolled asthma ...
In January 2004, tiotropium bromide (Spiriva; Boehringer Ingelheim/Pfizer), an orally inhaled anticholinergic drug, was approved by the US FDA for the treatment of chronic obstructive pulmonary ...
September 20, 2010 (Barcelona, Spain) — Adding the anticholinergic agent tiotropium bromide (Spiriva, Boehringer-Ingelheim and Pfizer), approved for the treatment of chronic obstructive pulmonary ...
SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...
Tiotropium as Asthma Add-On Treatment Shows Promise Boehringer Ingelheim announced that Spiriva Respimat (tiotropium bromide) Inhalation Spray is now available. The Respimat formulation uses ...
Spiriva (tiotropium bromide) is a long-acting bronchodilator prescribed for certain respiratory conditions. It isn’t meant for sudden breathing problems. You should not combine Spiriva with other ...
Details concerning the Tiotropium Bromide combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Boehringer Ingelheim announced the launch of Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray for the long-term maintenance treatment of airflow obstruction in patients with COPD, ...
Positive conclusion of a European DCP for approval of a tiotropium bromide-based maintenance treatment for those people living with COPD in a new inhaler (Zonda®) "We are all excited at the news of ...
Tiotropium bromide is a new quaternary ammonium compound with anticholinergic properties specific for muscarinic receptors (M1, M2, and M3) in humans. [1] Because acetylcholine modulates bronchial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results